We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drops Controversial Presubmissions IDE Process in Final Clinical Trials Guidance
FDA Drops Controversial Presubmissions IDE Process in Final Clinical Trials Guidance
Citing industry concerns, the FDA has reversed plans for a proposed voluntary presubmission process that would have allowed sponsors to get reviewer feedback before submitting an investigational device exemption application.